ReviewRheumatology advances in practice2023
Current and future advances in practice: a practical approach to the diagnosis and management of primary central nervous system vasculitis.
Review in Rheumatology advances in practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.
- Intracranial GCA: a comprehensive systematic review.Rheumatology (Oxford, England) · 2025Pooled it
- Granulomatous Diseases of the CNS: Aetiology, Neuroradiological Features and Clinical Findings.Clinical neuroradiology · 2026Review
- Graves' disease-related reversible intracranial arteriopathy presenting with ischemic stroke: A case report and literature review.Medicine · 2026Review
- Inside the Heterogeneity of Primary CNS Vasculitis: A Single-Center 40-Year Experience.Neurology(R) neuroimmunology & neuroinflammation · 2026Article
- Review
- Central nervous system vasculitis mimicking a brain tumor: A case report.Radiology case reports · 2026Article
- Clinical and Radiological Outcomes of Angiographically Proven Central Nervous System Arteriopathy.Cureus · 2025Article
- Advancing Knowledge in CNS Vasculitis.Neurology(R) neuroimmunology & neuroinflammation · 2024Article
- Navigating gaps in evidence to inform current and future practice in rheumatology.Rheumatology advances in practice · 2023Article
- Coincidence of Takayasu Arteritis and Multiple Sclerosis: Narrative Review and Case Report.Biomedicine hubArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary CNS vasculitis (CNSV) is a rare, idiopathic autoimmune disease that, if untreated, can cause significant morbidity and mortality. It is a challenging diagnosis due to multiple mimics that can be difficult to differentiate, given that the CNS is an immunologically privileged and structurally isolated space. As such, diagnosis requires comprehensive multimodal investigations. Usually, a brain biopsy is required to confirm the diagnosis. Treatment of CNSV involves aggressive immunosuppression, but relapses and morbidity remain common. This expert review provides the reader with a deeper understanding of presentations of CNSV and the multiple parallel diagnostic pathways that are required to diagnose CNSV (and recognize its mimics), highlights the important knowledge gaps that exist in the disease and also highlights how we might be able to care for these patients better in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.